The RPRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the RPRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The RPRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View RPRX Detailed Price Forecast - CNN Money||View RPRX Detailed Summary - Google Finance|
|View RPRX Detailed Summary - Yahoo! Finance||View RPRX Stock Research & Analysis - Zacks.com|
|View RPRX Trends & Analysis - Trade-Ideas||View RPRX Major Holders - Barrons|
|View RPRX Call Transcripts - NASDAQ||View RPRX Breaking News & Analysis - Seeking Alpha|
|View RPRX Annual Report - CompanySpotlight.com||View RPRX OTC Short Report - OTCShortReport.com|
|View RPRX Fundamentals - TradeKing||View RPRX SEC Filings - Bar Chart|
|View Historical Prices for RPRX - The WSJ||View Performance/Total Return for RPRX - Morningstar|
|View the Analyst Estimates for RPRX - MarketWatch||View the Earnings History for RPRX - CNBC|
|View the RPRX Earnings - StockMarketWatch||View RPRX Buy or Sell Recommendations - MacroAxis|
|View the RPRX Bullish Patterns - American Bulls||View RPRX Short Pain Metrics - ShortPainBot.com|
|View RPRX Stock Mentions - StockTwits||View RPRX Stock Mentions - PennyStockTweets|
|View RPRX Stock Mentions - Twitter||View RPRX Investment Forum News - Investor Hub|
|View RPRX Stock Mentions - Yahoo! Message Board||View RPRX Stock Mentions - Seeking Alpha|
|View Insider Transactions for RPRX - SECform4.com||View Insider Transactions for RPRX - Insider Cow|
|View RPRX Major Holdings Summary - CNBC||View Insider Disclosure for RPRX - OTC Markets|
|View Insider Transactions for RPRX - Yahoo! Finance||View Institutional Holdings for RPRX - NASDAQ|
|View RPRX Stock Insight & Charts - FinViz.com||View RPRX Investment Charts - StockCharts.com|
|View RPRX Stock Overview & Charts - BarChart||View RPRX User Generated Charts - Trading View|
Repros Announces Negative Opinion From the EMA for Enclomiphene
Posted on Friday January 26, 2018
THE WOODLANDS, Texas, Jan. 26, 2018-- Repros Therapeutics Inc. ®, today announced that, consistent with the previously disclosed guidance from the European Medicines Agency, the CHMP, a committee of the ...
NEW YORK, Jan. 9, 2018 /PRNewswire/ -- Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court Southern District of Texas Houston Division, case no. 4:17-cv-03918, on behalf of stockholders of Repros Therapeutics Inc. ("Repros" or the "Company") (RPRX) who held Repros securities and have been harmed by Repros and its board of directors' (the "Board") for alleged violations of Sections 14(d)(4), 14(e), and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") in connection with the tender offer of Company common stock to be purchased by Allergan plc ("Allergan"). Under the terms of the agreement, Repros stockholders are only anticipated to receive $0.67 per share in cash in exchange for each share of Repros. The complaint alleges that this offer is inadequate and alleges that the Schedule 14D-9 Solicitation/Recommendation Statement (the "Recommendation Statement") provides materially incomplete and misleading information about the Company's financials and the transaction, in violation of Sections 14(d)(4), 14(e), and 20(a) of the Exchange Act.
Detailed Research: Economic Perspectives on Athersys, Repros Therapeutics, GCP Applied Technologies, IDACORP, Mobile Mini, and Corindus Vascular Robotics — What Drives Growth in Today's Competitive Landscape
Posted on Thursday January 04, 2018
NEW YORK, Jan. 04, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Athersys, ...
Repros Therapeutics Inc (NASDAQ:RPRX): Is Healthcare An Attractive Sector Play?
Posted on Friday December 29, 2017
Repros Therapeutics Inc (NASDAQ:RPRX), a USD$25.52M small-cap, is a healthcare company operating in an industry, which continues to be affected by the sustained economic uncertainty and structural trends, such asRead More...